Literature DB >> 15500620

Heterogeneous expression of apolipoprotein-E by human macrophages.

Nicodemus Tedla1, Elias N Glaros, Ulf T Brunk, Wendy Jessup, Brett Garner.   

Abstract

Apolipoprotein-E (apoE) is expressed at high levels by macrophages. In addition to its role in lipid transport, macrophage-derived apoE plays an important role in immunoregulation. Previous studies have identified macrophage subpopulations that differ substantially in their ability to synthesize specific cytokines and enzymes, however, potential heterogeneous macrophage apoE expression has not been studied. Here we examined apoE expression in human THP-1 macrophages and monocyte-derived macrophages (MDM). Using immunocytochemistry and flow cytometry methods we reveal a striking heterogeneity in macrophage apoE expression in both cell types. In phorbol-ester-differentiated THP-1 macrophages, 5% of the cells over-expressed apoE at levels more than 50-fold higher than the rest of the population. ApoE over-expressing THP-1 macrophages contained condensed/fragmented nuclei and increased levels of activated caspase-3 indicating induction of apoptosis. In MDM, 3-5% of the cells also highly over-expressed apoE, up to 50-fold higher than the rest of the population; however, this was not associated with obvious nuclear alterations. The apoE over-expressing MDM were larger, more granular, and more autofluorescent than the majority of cells and they contained numerous vesicle-like structures that appeared to be coated by apoE. Flow cytometry experiments indicated that the apoE over-expressing subpopulation of MDM were positive for CD14, CD11b/Mac-1 and CD68. These observations suggest that specific macrophage subpopulations may be important for apoE-mediated immunoregulation and clearly indicate that subpopulation heterogeneity should be taken into account when investigating macrophage apoE expression.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15500620      PMCID: PMC1782582          DOI: 10.1111/j.1365-2567.2004.01972.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  63 in total

1.  Apolipoprotein E is a biologically active constituent of the normal immunoregulatory lipoprotein, LDL-In.

Authors:  M G Pepe; L K Curtiss
Journal:  J Immunol       Date:  1986-05-15       Impact factor: 5.422

2.  Characterization of subsets of bone marrow-derived macrophages by flow cytometry analysis.

Authors:  E B Walker; E T Akporiaye; N L Warner; C C Stewart
Journal:  J Leukoc Biol       Date:  1985-02       Impact factor: 4.962

3.  Biochemical and genetic studies of the apoprotein E secreted by mouse macrophages and human monocytes.

Authors:  S K Basu; Y K Ho; M S Brown; D W Bilheimer; R G Anderson; J L Goldstein
Journal:  J Biol Chem       Date:  1982-08-25       Impact factor: 5.157

4.  Cord blood plasma lipoproteins inhibit mitogen-stimulated lymphocyte proliferation.

Authors:  L K Curtiss; T M Forte; P A Davis
Journal:  J Immunol       Date:  1984-09       Impact factor: 5.422

5.  Mouse macrophages synthesize and secrete a protein resembling apolipoprotein E.

Authors:  S K Basu; M S Brown; Y K Ho; R J Havel; J L Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

Review 6.  The cell and molecular biology of apolipoprotein E synthesis by macrophages.

Authors:  Z Werb; J R Chin; R Takemura; R L Oropeza; D F Bainton; P Stenberg; J M Taylor; C Reardon
Journal:  Ciba Found Symp       Date:  1986

7.  Cells of a human monocytic leukemia cell line (THP-1) synthesize and secrete apolipoprotein E and lipoprotein lipase.

Authors:  S Tajima; R Hayashi; S Tsuchiya; Y Miyake; A Yamamoto
Journal:  Biochem Biophys Res Commun       Date:  1985-01-16       Impact factor: 3.575

Review 8.  Apolipoprotein E: cholesterol transport protein with expanding role in cell biology.

Authors:  R W Mahley
Journal:  Science       Date:  1988-04-29       Impact factor: 47.728

9.  The LDL-receptor-related protein, LRP, is an apolipoprotein E-binding protein.

Authors:  U Beisiegel; W Weber; G Ihrke; J Herz; K K Stanley
Journal:  Nature       Date:  1989-09-14       Impact factor: 49.962

10.  Transcriptional activation of the lipoprotein lipase and apolipoprotein E genes accompanies differentiation in some human macrophage-like cell lines.

Authors:  J H Auwerx; S Deeb; J D Brunzell; R Peng; A Chait
Journal:  Biochemistry       Date:  1988-04-19       Impact factor: 3.162

View more
  5 in total

1.  Proteomic and biochemical analysis of purified human immunodeficiency virus type 1 produced from infected monocyte-derived macrophages.

Authors:  Elena Chertova; Oleg Chertov; Lori V Coren; James D Roser; Charles M Trubey; Julian W Bess; Raymond C Sowder; Eugene Barsov; Brian L Hood; Robert J Fisher; Kunio Nagashima; Thomas P Conrads; Timothy D Veenstra; Jeffrey D Lifson; David E Ott
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

Review 2.  Cell-specific production, secretion, and function of apolipoprotein E.

Authors:  Maaike Kockx; Mathew Traini; Leonard Kritharides
Journal:  J Mol Med (Berl)       Date:  2018-03-07       Impact factor: 4.599

3.  Macrophage LRP-1 controls plaque cellularity by regulating efferocytosis and Akt activation.

Authors:  Patricia G Yancey; John Blakemore; Lei Ding; Daping Fan; Cheryl D Overton; Youmin Zhang; MacRae F Linton; Sergio Fazio
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-02-11       Impact factor: 8.311

Review 4.  Macrophage Apoptosis and Efferocytosis in the Pathogenesis of Atherosclerosis.

Authors:  MacRae F Linton; Vladimir R Babaev; Jiansheng Huang; Edward F Linton; Huan Tao; Patricia G Yancey
Journal:  Circ J       Date:  2016-10-08       Impact factor: 2.993

Review 5.  The Genetic Variability of APOE in Different Human Populations and Its Implications for Longevity.

Authors:  Paolo Abondio; Marco Sazzini; Paolo Garagnani; Alessio Boattini; Daniela Monti; Claudio Franceschi; Donata Luiselli; Cristina Giuliani
Journal:  Genes (Basel)       Date:  2019-03-15       Impact factor: 4.096

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.